People

Olivia Nixon-Hemelt, MD
MD: University of Texas Medical Branch John Sealy School of Medicine
I am so excited to have matched at Washington University in St. Louis! The opportunity to train with such excellent clinicians and researchers is undoubtedly an honor, but what ultimately sealed my decision was the authenticity and kindness of the faculty and residents that I met on my interview day. The thoughtfulness, innovation, and excellence with which WashU approaches patient care is unmatched. I feel so honored to join the ranks!

Carly Novelly, CCC-SLP
Speech-Language Pathologist
Otolaryngology—Head & Neck Surgery
Carly Novelly is a speech-language pathologist specializing in voice and upper airway disorders. Her clinical interests include endoscopic laryngeal imaging and videostroboscopy; evaluation and treatment of voice and upper airway disorders, including chronic cough; paradoxical vocal fold motion (PVFM); and aging voice/presbyphonia.

Margaret Allison Ogden, MD, FACS
Professor of Otolaryngology—Head and Neck Surgery
Castle Connolly Top Doctor

Kevin Ohlemiller, PhD
Professor of Otolaryngology—Head & Neck Surgery
Research Interests: Our research focuses on the role of genetics in the form and progression of age-related hearing loss (ARHL) and the role of genetics in the form and severity of noise-induced hearing loss (NIHL)

Bharat A. Panuganti, MD
Assistant Professor of Otolaryngology—Head & Neck Surgery
- Phone: 314-362-7509

Andrew Parker, MD
MD: Tulane University School of Medicine
I am delighted to join the WashU Otolaryngology family and incredibly grateful for the opportunity to continue my training at such a phenomenal program! During my sub-internship, I was impressed not only with residents’ surgical skill and clinical knowledge but also the kindness and support from residents and faculty alike

Guangyong Peng, MD, PhD
Professor of Otolaryngology—Head & Neck Surgery
Our lab’s research focuses on understanding the role of different subsets of T cells in suppressive tumor microenvironments and the development of novel tumor therapeutic strategies using metabolic and molecular reprogramming of T cell fate and function for enhanced tumor immunity and immunotherapy.